{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:54:22Z","timestamp":1791014062376,"version":"4.1.0"},"reference-count":29,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>Ubiquitin is suggested to play a key role in essential intracellular functions, such as heat shock response, protein breakdown, and regulation of immune responses. Ubiquitin has also been detected in the extracellular space, but the function and biologic significance is unclear. We describe a new function of extracellular ubiquitin and show that extracellular ubiquitin specifically inhibits ex vivo secretion of tumor necrosis factor-\u03b1 (TNF-\u03b1) and TNF-\u03b1 mRNA expression from peripheral blood mononuclear cells (PBMNCs) in response to endotoxin in a dose-dependent manner. In contrast, the TNF-\u03b1 response to zymosan or Staphylococcus aureus as well as the interleukin-6 (IL-6) and IL-8 responses to endotoxin were unaffected by ubiquitin. Measurement of serum ubiquitin levels showed a significant 5- to 7-fold increase in sepsis and trauma patients, to the level required for inhibition of the PBMNC TNF-\u03b1 response to endotoxin by ubiquitin. Elevated ubiquitin levels in serum were significantly correlated with a reduced TNF-\u03b1 production. Antibodies to ubiquitin were able to (1) significantly increase (2- to 5-fold) the TNF-\u03b1 response to endotoxin in whole blood from trauma and sepsis patients, (2) completely neutralize the inhibitory effect of trauma patients' serum on healthy donors' TNF-\u03b1 production, and (3) partially neutralize the inhibitory effect of sepsis patients' serum on healthy donors' TNF-\u03b1 production. Ubiquitin-depleted serum from trauma patients lost the inhibitory activity for TNF-\u03b1 production, whereas extracted endogenous ubiquitin exerts the inhibitory activity. The results demonstrate that extracellular ubiquitin acts as a cytokinelike protein with anti-inflammatory properties and indicate that extracellular ubiquitin is involved in the regulation of immunodepression in critical illness.<\/jats:p>","DOI":"10.1182\/blood-2002-03-0918","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T19:59:36Z","timestamp":1045079976000},"page":"1882-1890","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["Extracellular ubiquitin inhibits the TNF-\u03b1 response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness"],"prefix":"10.1182","volume":"101","author":[{"given":"Matthias","family":"Majetschak","sequence":"first","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Krehmeier","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bardenheuer","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Denz","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Quintel","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Voggenreiter","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Obertacke","sequence":"additional","affiliation":[{"name":"From the Department of Trauma Surgery, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany; and Department of Anaesthesiology, University Hospital Mannheim, Faculty of Clinical Medicine Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822423976500_B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.72.1.11","article-title":"Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells.","volume":"72","author":"Goldstein","year":"1975","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822423976500_B2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/312663a0","article-title":"The yeast ubiquitin gene: head-to-tail repeats encoding a polyubiquitin precursor protein.","volume":"312","author":"O\u0308zkaynak","year":"1984","journal-title":"Nature."},{"key":"2019111822423976500_B3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system.","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem."},{"key":"2019111822423976500_B4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1097-2765(01)00347-1","article-title":"Ubiquitin enters the new millennium. Meeting review.","volume":"8","author":"Pickart","year":"2001","journal-title":"Mol Cell."},{"key":"2019111822423976500_B5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ni0102-20","article-title":"Regulatory functions of ubiquitination in the immune system.","volume":"1","author":"Ben-Neriah","year":"2002","journal-title":"Nat Immunol."},{"key":"2019111822423976500_B6","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/j.1460-2075.1992.tb05379.x","article-title":"In vivo function of the proteasome in the ubiquitin pathway.","volume":"11","author":"Seufert","year":"1992","journal-title":"EMBO J."},{"key":"2019111822423976500_B7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-1759(94)90286-0","article-title":"A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases.","volume":"173","author":"Asseman","year":"1994","journal-title":"J Immunol Methods."},{"key":"2019111822423976500_B8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1530-0277.1999.tb04539.x","article-title":"Serum ubiquitin levels in patients with alcoholic liver disease.","volume":"23","author":"Takagi","year":"1999","journal-title":"Alcohol Clin Exp Res."},{"key":"2019111822423976500_B9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2337\/diacare.24.1.100","article-title":"Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes.","volume":"24","author":"Akarsu","year":"2001","journal-title":"Diabetes Care."},{"key":"2019111822423976500_B10","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood.V95.8.2577","article-title":"Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells.","volume":"95","author":"Daino","year":"2000","journal-title":"Blood."},{"key":"2019111822423976500_B11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(93)90042-3","article-title":"Increase in plasma concentrations of ubiquitin in dialysis patients: possible involvement in beta 2-microglobulin amyloidosis.","volume":"5","author":"Okada","year":"1993","journal-title":"Clin Chim Acta."},{"key":"2019111822423976500_B12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000046005","article-title":"Relation between serum ubiquitin levels and KT\/V in chronic hemodialysis patients.","volume":"88","author":"Akarsu","year":"2001","journal-title":"Nephron."},{"key":"2019111822423976500_B13","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/eji.1830211113","article-title":"Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL).","volume":"21","author":"Pancre","year":"1991","journal-title":"Eur J Immunol."},{"key":"2019111822423976500_B14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.156.2.532","article-title":"Ubiquitin-like moiety of the monoclonal nonspecific suppressor factor beta is responsible for its activity.","volume":"156","author":"Nakamura","year":"1996","journal-title":"J Immunol."},{"key":"2019111822423976500_B15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-4889(99)00024-5","article-title":"Synergistic effect of ubiquitin on lipopolysaccharide-induced TNF alpha production in murine macrophage cell line Raw 264.7.","volume":"1450","author":"Nabika","year":"1999","journal-title":"Biochim Biophys Acta."},{"key":"2019111822423976500_B16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/bbrc.1996.0875","article-title":"Extracellular ubiquitin regulates the growth of human hematopoietic cell.","volume":"223","author":"Daino","year":"1996","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111822423976500_B17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.","volume":"3","author":"Docke","year":"1997","journal-title":"Nat Med."},{"key":"2019111822423976500_B18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000058753","article-title":"Clinical aspects: from systemic inflammation to \u201cimmunoparalysis.\u201d","volume":"74","author":"Volk","year":"2000","journal-title":"Chem Immunol."},{"key":"2019111822423976500_B19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005373-198501000-00010","article-title":"Abbreviated injury scale and injury severity score: a scoring chart.","volume":"25","author":"Greenspan","year":"1985","journal-title":"J Trauma."},{"key":"2019111822423976500_B20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference","year":"1992","journal-title":"Crit Care Med."},{"key":"2019111822423976500_B21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colometric assay for cellular growth and survival: application to proliferation and cytotoxity assays.","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods."},{"key":"2019111822423976500_B22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1084\/jem.181.5.1887","article-title":"Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor \u03b2.","volume":"181","author":"Randow","year":"1985","journal-title":"J Exp Med."},{"key":"2019111822423976500_B23","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1182\/blood.V98.13.3800","article-title":"High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.","volume":"98","author":"Zweigner","year":"2001","journal-title":"Blood."},{"key":"2019111822423976500_B24","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood.V89.5.1612","article-title":"Inhibition of the defense system stimulating interleukin-12 interferon-\u03b3 pathway during critical illness.","volume":"89","author":"Ertel","year":"1997","journal-title":"Blood."},{"key":"2019111822423976500_B25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00003246-200006000-00027","article-title":"Diminished endotoxin induced whole blood TNF-\u03b1 production and its relation to systemic concentrations of interleukin-4, interleukin-10 and transforming growth factor-\u03b21 in multiply injured patients.","volume":"28","author":"Majetschak","year":"2000","journal-title":"Crit Care Med."},{"key":"2019111822423976500_B26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/clinchem\/43.7.1188","article-title":"Serum concentrations of free ubiquitin and multiubiquitin chains.","volume":"43","author":"Takada","year":"1997","journal-title":"Clin Chem."},{"key":"2019111822423976500_B27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1432-1327.1998.2550482.x","article-title":"The ubiquityl-calmodulin-synthetase system from rabbit reticulocytes: isolation of the ubiquitin binding first component, a truncated form of the ubiquitin activating enzyme.","volume":"255","author":"Majetschak","year":"1998","journal-title":"Eur J Biochem."},{"key":"2019111822423976500_B28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.184.1.51","article-title":"Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.","volume":"184","author":"Brandtzaeg","year":"1996","journal-title":"J Exp Med."},{"key":"2019111822423976500_B29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00003246-199902000-00037","article-title":"The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries.","volume":"27","author":"Majetschak","year":"1999","journal-title":"Crit Care Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1882\/1262475\/h80503001882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1882\/1262475\/h80503001882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T15:38:52Z","timestamp":1704641932000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/5\/1882\/106662\/Extracellular-ubiquitin-inhibits-the-TNF%CE%B1-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-03-0918","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}